Accueil/Actions/EDIT

EDIT

USD

Editas Medicine Inc. Common Stock

$2.780-0.160 (-5.442%)

Prix en Temps Réel

Healthcare

Biotechnologie

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$2.940

Haut

$2.980

Bas

$2.770

Volume

1.51M

Fondamentaux de l'Entreprise

Capitalisation Boursière

250.0M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

2.47M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $0.91Actuel $2.780Haut $4.537

Actualités Connexes

3 nov. 2025 · 14:00

GlobeNewswire

Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025

CAMBRIDGE, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced a

Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025

Actions Connexes

HBB

Hamilton Beach Brands Holding Company

NASDAQ

Ameublement de ...

GJP

Synthetic Fixed-Income Securities Inc. on behalf of STRATS (SM) Trust for Dominion Resources Inc. Securities Series 2005-6 Floating Rate Structured Repackaged Asset-Backed Trust Securities (STRATS) Certificates

NASDAQ

Finance : Servi...